Carboxypeptidase G2
RxNorm 1242127
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1242127 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Carboxypeptidase G2.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Carboxypeptidase G2
(Atom ID: 62573)
INPrescribable
Ingredient (IN):
Glucarpidase
(Atom ID: 4240589)
PTPrescribable
Designated preferred name (PT):
Glucarpidase
(Atom ID: 8244160)
FNPrescribable
Full form of descriptor (FN):
Glucarpidase (substance)
(Atom ID: 8244161)
PTPrescribable
Designated preferred name (PT):
Glucarpidase-containing product
(Atom ID: 10803707)
FNPrescribable
Full form of descriptor (FN):
Product containing glucarpidase (medicinal product)
(Atom ID: 10306886)
Patient Education
Glucarpidase
Glucarpidase is used to prevent harmful effects of methotrexate (Rheumatrex, Trexall) in patients with kidney disease who are receiving methotrexate to treat certain types of cancer. Glucarpidase is in a class of medications called enzymes. It works by helping to break down and remove methotrexate from the body.
[Learn More]
* Please review the disclaimer below.